Xtant Medical Holdings (XTNT) Depreciation & Amortization (CF) (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $1.5 million in Q4 2025.

• Depreciation & Amortization (CF) for Q4 2025 came in at $1.5 million, up 30.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.9 million (up 16.1% YoY), and the FY2025 annual result was $3.6 million, down 14.77% from the prior year.
• Depreciation & Amortization (CF) advanced to $1.5 million in Q4 2025 per XTNT's latest filing, from $1.2 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.5 million in Q4 2025 and troughed at $281000.0 in Q1 2022.
• A 5-year average of $746300.0 and a median of $843000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2021 and 2023: Depreciation & Amortization (CF) plunged 45.26% in 2021, then surged 216.82% in 2023.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $291000.0 in 2021, then grew by 10.31% to $321000.0 in 2022, then surged by 216.82% to $1.0 million in 2023, then gained by 12.88% to $1.1 million in 2024, then soared by 30.66% to $1.5 million in 2025.
• Business Quant data shows XTNT's Depreciation & Amortization (CF) at $1.5 million in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.